Biofilms on Microplastics and Viral Dynamics
Act as a reservoir for viruses. 1, 2, 3, 4
Decision logic (prioritizing morbidity, mortality, and QOL implications):
- Highest-quality, most recent primary evidence shows viral genomes on biofilm-coated microplastics, including clinically relevant pathogens (e.g., norovirus), sometimes present on particles when absent from surrounding treated water—supporting a reservoir and carrier role 1.
- Metagenomic studies demonstrate specialized viral assemblages, enrichment of virulence/antibiotic-resistance functions, and dominance of active viral lifestyles within microplastic biofilms—consistent with persistence and reservoir potential 2.
- State-of-the-science reviews conclude that biofilm and eco-corona formation on microplastics enhances viral adsorption, stability, transport, and potentially infectivity, elevating public-health risk—further supporting a reservoir function impacting morbidity/mortality/QOL 3, 4.
Why other options are inferior/incorrect:
- Prevent viral attachment: Contradicted by evidence of viral adsorption to biofilm-coated particles 1, 3.
- Accelerate viral inactivation: Evidence instead supports prolonged persistence/stability on biofilm-coated plastics 3, 4.
- Inhibit viral mutations: No supporting evidence; some studies note enriched gene exchange potential in plastisphere communities, implying the opposite trend risk 2.
Pitfalls/caveats to avoid:
- Absence of culture-based infectivity data in some studies; however, detection of pathogenic viral genomes on microplastics and concordant mechanistic reviews justify treating biofilm-coated microplastics as viral reservoirs in real-world risk assessment 1, 3.
- Heterogeneity by polymer type and biofilm composition may modulate risk, but reservoir role remains across contexts 5, 2.